OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
Companies

Health Care

Coverage of health care companies under Platform analysis-pipeline.

Sub-sectors of Healthcare

3
Sector ETFXLVHealth Care Select Sector SPDR
Policy pressureNET -2avg severity 3.5See bills →
0 bullish0 mixed2 bearish
Top moverslast close vs prior close · 1413 tickers in sector
Peer cohort medianspeer cohort · industry-most-specific level
Pharmaceuticals & Medical Research1 cos · 545 covered
Activity
Op margin-8.0%
Net margin28.2%
Gross margin45.6%
Pharmaceuticals1 cos · 513 covered
Activity
Op margin29.0%
Net margin21.8%
Gross margin66.3%
R&D / revenue23.1%
Healthcare Services & Equipment5 cos · 336 covered
Activity
Op margin13.3%
Net margin8.6%
Gross margin64.0%
R&D / revenue6.9%
Healthcare Diagnostics232 cos · 285 covered
Activity
Op margin7.0%
Net margin2.4%
Gross margin49.7%
Biotechnology9 cos · 121 covered
Activity
Op margin11.5%
Net margin8.6%
Gross margin28.8%
Advanced Medical Equipment & Technology3 cos · 114 covered
Activity
Op margin19.4%
Net margin17.7%
Gross margin73.5%
R&D / revenue6.2%
Healthcare Equipment141 cos · 104 covered
Activity
Op margin-30.2%
Net margin-28.3%
Gross margin49.0%
Top companies showing 50 of 2018
Sort by
CAHNYSE68

Cardinal Health Inc

Pharmaceuticals
Price$199.77
Mkt Cap
P/E
Revenue$129.64B
Op Income$1.38B
FCF$1.42B

Cardinal Health's capital structure is highly leveraged, with a debt-to-equity ratio of -2.89, indicating that the company's liabilities significantly exceed its equity. The company's liquidity pos…

Dilution: Unknown · Liquidity: High
CORNYSE68

Cencora, Inc.

Medical Equipment, Supplies & Distribution
Price$265.30
Mkt Cap
P/E
Revenue$85.93B
Op Income$760.4M
FCF-$2.42B

Cencora's capital structure is highly leveraged, with a debt-to-equity ratio of 3.97, indicating significant reliance on debt financing. The company's liquidity position is strained, as evidenced b…

Dilution: Medium · Liquidity: High
CVSNYSE68

CVS HEALTH Corp

Healthcare Facilities & Services
Price$96.00
Mkt Cap
P/E
Revenue$402.07B
Op Income$4.66B
FCF$7.81B

CVS Health maintains a debt-to-equity ratio of 0.8, indicating a relatively conservative capital structure compared to the industry median of 1.2. The company's liquidity position is characterized…

Dilution: Medium · Liquidity: High
WATNYSE68

Waters Corp /de/

Advanced Medical Equipment & Technology
Price$332.19
Mkt Cap
P/E
Revenue$3.17B
Op Income$802.6M
FCF

Waters Corporation maintains a strong liquidity position with $587.83 million in cash and equivalents, but its net cash is negative after subtracting total debt of $947.45 million. The company's li…

Dilution: Medium · Liquidity: Medium
EWNYSE68

Edwards Lifesciences Corp

Advanced Medical Equipment & Technology
Price$82.39
Mkt Cap
P/E
Revenue$6.07B
Op Income$1.26B
FCF$1.33B

Edwards Lifesciences Corp maintains a strong liquidity position with a current ratio of 3.72, indicating the company can easily cover its short-term liabilities with its current assets. The company…

Dilution: Medium · Liquidity: Low
RMDNYSE68

Resmed Inc

Advanced Medical Equipment & Technology
Price$204.15
Mkt Cap
P/E
Revenue$2.76B
Op Income$938.2M
FCF$725.6M

Capital Structure and Liquidity ResMed maintains a strong liquidity position with a current ratio of 3.06 and a debt-to-equity ratio of 0.04, indicating a conservative capital structure. The compan…

Dilution: Medium · Liquidity: Low
ANYSE68

Agilent Technologies, Inc.

Advanced Medical Equipment & Technology
Price$112.00
Mkt Cap
P/E
Revenue$1.80B
Op Income$353.0M
FCF$175.0M

Agilent Technologies, Inc. maintains a strong liquidity position with a current ratio of 2.07 and cash and equivalents of $1.76 billion, indicating a solid ability to meet short-term obligations. T…

Dilution: Medium · Liquidity: Low
ABTNYSE68

Abbott Laboratories

Medical Equipment, Supplies & Distribution
Price$87.80
Mkt Cap$153.39B
P/E150.1
Revenue$11.16B
Op Income$1.34B
FCF$916.0M

Abbott Laboratories maintains a capital structure with a debt-to-equity ratio of 0.65, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a curre…

Dilution: Medium · Liquidity: Medium
JNJNYSE68

Johnson & Johnson

Pharmaceuticals
Price$228.88
Mkt Cap$559.66B
P/E107.5
Revenue$24.06B
Op Income
FCF$1.47B

Johnson & Johnson maintains a strong liquidity position with a current ratio of 1.03, though it is close to the minimum comfort range. The company has $21.69 billion in cash and equivalents but als…

Dilution: Medium · Liquidity: High
LLYNYSE68

Eli Lilly & Co

Pharmaceuticals
Price$989.00
Mkt Cap$886.05B
P/E114.1
Revenue$19.80B
Op Income
FCF

Eli Lilly's capital structure is characterized by a high debt-to-equity ratio of 1.26, indicating a significant reliance on debt financing. The company's liquidity position is moderate, with a curr…

Dilution: Unknown · Liquidity: Medium
BDXNYSE68

Becton Dickinson & Co

Medical Equipment, Supplies & Distribution
Price$142.75
Mkt Cap
P/E
Revenue$5.25B
Op Income$552.0M
FCF$549.0M

BDX's capital structure is characterized by a debt-to-equity ratio of 0.67, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as high, but its current r…

Dilution: Medium · Liquidity: High
CHENYSE68

Chemed Corp

Healthcare Facilities & Services
Price$441.62
Mkt Cap
P/E
Revenue$657.5M
Op Income$84.6M
FCF$71.1M

Chemed's capital structure is characterized by a low debt-to-equity ratio of 0.11, indicating a conservative leverage position relative to its equity base. The company maintains a current ratio of…

Dilution: Medium · Liquidity: High
HAENYSE68

Haemonetics Corp

Medical Equipment, Supplies & Distribution
Price$57.28
Mkt Cap
P/E
Revenue$987.7M
Op Income$179.8M
FCF$207.2M

Haemonetics maintains a debt-to-equity ratio of 1.34 and a current ratio of 1.75, indicating moderate leverage and adequate short-term liquidity. The company's liquidity position is supported by $3…

Dilution: Medium · Liquidity: Medium
LHNYSE68

Labcorp Holdings Inc.

Healthcare Facilities & Services
Price$255.57
Mkt Cap
P/E
Revenue$13.95B
Op Income$1.38B
FCF$1.21B

Labcorp's capital structure is characterized by a debt-to-equity ratio of 0.65, indicating a moderate reliance on debt financing. The company maintains a current ratio of 1.42, suggesting it has su…

Dilution: Medium · Liquidity: Medium
MDTNYSE68

Medtronic plc

Medical Equipment, Supplies & Distribution
Price$77.49
Mkt Cap
P/E
Revenue$26.56B
Op Income$4.59B
FCF$3.34B

Medtronic's capital structure is characterized by a debt-to-equity ratio of 0.57, indicating a moderate level of leverage. The company's liquidity position is reflected in a current ratio of 2.54,…

Dilution: Low · Liquidity: Medium
PBHNYSE68

Prestige Consumer Healthcare Inc.

Pharmaceuticals
Price$46.60
Mkt Cap$2.29B
P/E20.2
Revenue$807.1M
Op Income$233.9M
FCF$208.8M

Prestige Consumer Healthcare Inc. has a market price of $56.29 and a market cap of $2.76 billion, with a price-to-earnings ratio of 20.25 and a price-to-book ratio of 2.54. The company's liquidity…

Dilution: Medium · Liquidity: Medium
TFXNYSE68

Teleflex Inc

Medical Equipment, Supplies & Distribution
Price$130.41
Mkt Cap
P/E
Revenue$1.99B
Op Income$118.4M
FCF

Teleflex's capital structure is characterized by a debt-to-equity ratio of 0.85, indicating a moderate reliance on debt financing. The company's liquidity position is reflected in a current ratio o…

Dilution: Medium · Liquidity: Medium
UHSNYSE68

Universal Health Services Inc

Healthcare Facilities & Services
Price$169.27
Mkt Cap
P/E
Revenue$17.36B
Op Income$1.99B
FCF$849.2M

Universal Health Services, Inc. maintains a debt-to-equity ratio of 0.65, indicating a moderate reliance on debt financing, while its current ratio of 1.05 suggests a liquidity position that is nea…

Dilution: Medium · Liquidity: High
HCANYSE67

HCA Healthcare, Inc.

Healthcare Facilities & Services
Price$422.90
Mkt Cap
P/E
Revenue$19.11B
Op Income
FCF$895.0M

HCA Healthcare's capital structure is highly leveraged, with a debt-to-equity ratio of -7.01, indicating a significant reliance on debt financing. The company's liquidity position is strained, as e…

Dilution: Low · Liquidity: High
IQVNYSE67

Iqvia Holdings Inc.

Biotechnology & Medical Research
Price$172.81
Mkt Cap
P/E
Revenue$16.31B
Op Income$2.18B
FCF

IQVIA's capital structure is characterized by a high debt-to-equity ratio of 2.42, indicating a significant reliance on debt financing. The company's liquidity position is constrained, with a curre…

Dilution: Medium · Liquidity: High
PENNYSE67

Penumbra Inc

Medical Equipment, Supplies & Distribution
Price$326.54
Mkt Cap
P/E
Revenue$1.40B
Op Income$189.2M
FCF$174.9M

Capital Structure and Liquidity Penumbra maintains a robust liquidity position with a current ratio of 6.64, indicating strong short-term financial health. The company's debt-to-equity ratio is 0.0…

Dilution: Low · Liquidity: Low
STENYSE67

STERIS plc

Medical Equipment, Supplies & Distribution
Price$212.87
Mkt Cap
P/E
Revenue$4.35B
Op Income$785.0M
FCF$727.2M

Capital Structure and Liquidity STERIS maintains a debt-to-equity ratio of 0.27, indicating a relatively conservative capital structure. The company's liquidity position is characterized as medium…

Dilution: Medium · Liquidity: Medium
CONNYSE67

Concentra Group Holdings Parent, Inc.

Healthcare Facilities & Services
Price$26.08
Mkt Cap
P/E
Revenue$2.16B
Op Income$334.0M
FCF$197.1M

Concentra Group Holdings Parent, Inc. has a liquidity position that is considered high, with a current ratio of 1.14, which is close to the minimum comfort range. The company's liquidity is further…

Dilution: Medium · Liquidity: High
DVANYSE67

Davita Inc.

Healthcare Facilities & Services
Price$199.52
Mkt Cap
P/E
Revenue$13.64B
Op Income$2.04B
FCF$1.31B

DaVita Inc. has a capital structure marked by a high debt load, with long-term debt of $10.16 billion and total liabilities of $16.32 billion, compared to total assets of $17.48 billion. The compan…

Dilution: High · Liquidity: Medium
UNHNYSE67

Unitedhealth Group Inc

Managed Healthcare
Price$390.30
Mkt Cap$355.56B
P/E27.9
Revenue$447.57B
Op Income$18.96B
FCF$16.07B

UnitedHealth Group maintains a strong liquidity position with a current ratio of 0.79 and cash and equivalents of $24.365 billion, but its liquidity is constrained by current liabilities exceeding…

Dilution: Medium · Liquidity: High
ZTSNYSE67

Zoetis Inc.

Pharmaceuticals
Price$78.45
Mkt Cap
P/E
Revenue$9.47B
Op Income
FCF$2.28B

Capital Structure and Liquidity Zoetis maintains a debt-to-equity ratio of 2.71, indicating a capital structure heavily reliant on debt financing. The company's liquidity position is characterized…

Dilution: High · Liquidity: Medium
BKDNYSE67

Brookdale Senior Living Inc.

Healthcare Facilities & Services
Price$13.22
Mkt Cap
P/E
Revenue$3.19B
Op Income$13.5M
FCF$16.5M

Brookdale's capital structure is highly leveraged, with total liabilities of $5.996 billion and total equity of -$44.75 million, resulting in a debt-to-equity ratio of -95.92. The company maintains…

Dilution: Medium · Liquidity: High
HUMNYSE67

Humana Inc

Managed Healthcare
Price$306.00
Mkt Cap$36.92B
P/E24.1
Revenue$39.65B
Op Income$1.75B
FCF$1.13B

Humana's capital structure is supported by a liquidity position of $4.95 billion in cash and equivalents, with a current ratio of 1.77, indicating strong short-term liquidity. The company's price-t…

Dilution: Medium · Liquidity: Low
THCNYSE67

Tenet Healthcare Corp

Healthcare Facilities & Services
Price$192.45
Mkt Cap
P/E
Revenue$5.37B
Op Income$1.30B
FCF$1.46B

Tenet Healthcare's capital structure is characterized by a debt-to-equity ratio of 2.73, indicating a significant reliance on debt financing. The company maintains a current ratio of 1.36, suggesti…

Dilution: Medium · Liquidity: Medium
DGXNYSE67

Quest Diagnostics Inc

Healthcare Facilities & Services
Price$189.84
Mkt Cap
P/E
Revenue$2.90B
Op Income$399.0M
FCF$164.0M

Quest Diagnostics has a liquidity position with a current ratio of 1.18, indicating a moderate ability to meet short-term obligations, though it is close to the minimum comfort range. The company's…

Dilution: Medium · Liquidity: High
NHCNYSE67

National Healthcare Corp

Healthcare Facilities & Services
Price$196.30
Mkt Cap
P/E
Revenue$1.52B
Op Income$128.4M
FCF$148.6M

NHC maintains a strong liquidity position with a current ratio of 1.82 and $92.8 million in cash and equivalents, indicating sufficient short-term liquidity to cover obligations. The company's debt…

Dilution: Medium · Liquidity: Low
TMONYSE67

Thermo Fisher Scientific Inc.

Advanced Medical Equipment & Technology
Price$443.00
Mkt Cap$167.45B
P/E26.3
Revenue$44.56B
Op Income$7.75B
FCF$6.29B

Thermo Fisher Scientific Inc. maintains a strong liquidity position with $9.85 billion in cash and equivalents, but its long-term debt of $35.85 billion results in a debt-to-equity ratio of 0.67, i…

Dilution: Medium · Liquidity: Medium
DHRNYSE67

Danaher Corp /de/

Advanced Medical Equipment & Technology
Price$163.86
Mkt Cap$116.54B
P/E123.7
Revenue$5.95B
Op Income$1.34B
FCF$1.08B

Capital Structure and Liquidity Danaher's capital structure is supported by a debt-to-equity ratio of 0.33, indicating a relatively conservative leverage position. The company maintains a current r…

Dilution: Medium · Liquidity: Medium
MDNYSE67

Pediatrix Medical Group, Inc.

Healthcare Facilities & Services
Price$22.64
Mkt Cap
P/E
Revenue
Op Income$208.8M
FCF

Capital Structure and Liquidity Pediatrix has a debt-to-equity ratio of 0.66, indicating a moderate level of leverage. The company's current ratio of 1.66 suggests it has sufficient short-term asse…

Dilution: Low · Liquidity: Medium
ZBHNYSE67

Zimmer Biomet Holdings, Inc.

Medical Equipment, Supplies & Distribution
Price$84.34
Mkt Cap
P/E
Revenue$8.23B
Op Income$1.10B
FCF$1.47B

Zimmer Biomet's capital structure is supported by a total equity of $12.7 billion and total liabilities of $10.4 billion, with a debt-to-equity ratio of 0.59. The company maintains a current ratio…

Dilution: Medium · Liquidity: Medium
BIONYSE66

Bio-rad Laboratories, Inc.

Medical Equipment, Supplies & Distribution
Price$281.82
Mkt Cap
P/E
Revenue$592.1M
Op Income$34.1M
FCF$78.1M

Capital Structure and Liquidity Bio-Rad maintains a strong liquidity position with $507.2 million in cash and equivalents and a current ratio of 3.21, indicating robust short-term financial health.…

Dilution: Medium · Liquidity: Low
MOHNYSE66

Molina Healthcare, Inc.

Managed Healthcare
Price$184.88
Mkt Cap
P/E
Revenue$10.80B
Op Income$83.0M
FCF$1.05B

Molina Healthcare maintains a strong liquidity position with $5.42 billion in cash and equivalents as of March 31, 2026, and a current ratio of 1.63, indicating sufficient short-term liquidity to c…

Dilution: Medium · Liquidity: Low
CNCNYSE66

Centene Corp

Managed Healthcare
Price$58.20
Mkt Cap
P/E
Revenue$44.66B
Op Income$1.86B
FCF$4.17B

Centene's capital structure shows a debt-to-equity ratio of 0.76, indicating moderate leverage. The company maintains strong liquidity with $21.26 billion in cash and equivalents, and a current rat…

Dilution: Low · Liquidity: Medium
SYKNYSE66

Stryker Corp

Medical Equipment, Supplies & Distribution
Price$313.22
Mkt Cap$121.06B
P/E37.5
Revenue$25.12B
Op Income$4.89B
FCF$4.28B

Stryker Corporation has a market capitalization of $121.8 billion and a price-to-earnings ratio of 37.52, indicating a premium valuation relative to earnings. The company's liquidity position is ch…

Dilution: Unknown · Liquidity: Medium
SEMNYSE66

Select Medical Holdings Corp

Healthcare Facilities & Services
Price$16.48
Mkt Cap
P/E
Revenue$1.42B
Op Income$98.4M
FCF

Select Medical Holdings Corp has a debt-to-equity ratio of 1.05, indicating a moderate reliance on debt financing, while its current ratio of 1.15 suggests limited short-term liquidity cushion. The…

Dilution: Medium · Liquidity: High
EHCNYSE65

Encompass Health Corp

Healthcare Facilities & Services
Price$106.10
Mkt Cap
P/E
Revenue$5.94B
Op Income
FCF

Capital Structure and Liquidity Encompass Health Corp maintains a debt-to-equity ratio of 1.0, indicating a balanced capital structure. The company's liquidity position is characterized by a curren…

Dilution: Unknown · Liquidity: High
PFENYSE65

Pfizer Inc

Pharmaceuticals
Price$25.30
Mkt Cap$144.54B
P/E19.6
Revenue$62.58B
Op Income
FCF$9.07B

PFIZER INC (PFE) is currently classified as Pharmaceuticals within Pharmaceuticals (Healthcare). Classification confidence: 0.92 (verified market data). Capital structure on the latest snapshot: to…

Dilution: Medium · Liquidity: High
CINYSE64

Cigna Group

Managed Healthcare
Price$286.68
Mkt Cap
P/E
Revenue$68.49B
Op Income$2.36B
FCF

Cigna Group (CI) is currently classified as Healthcare Services & Equipment within Managed Healthcare (Healthcare). Classification confidence: 0.92 (verified market data). Capital structure on the…

Dilution: Medium · Liquidity: High
BMYNYSE64

Bristol Myers Squibb Co

Pharmaceuticals
Price$57.35
Mkt Cap
P/E
Revenue$11.49B
Op Income
FCF$757.0M

BRISTOL MYERS SQUIBB CO (BMY) is currently classified as Pharmaceuticals within Pharmaceuticals (Healthcare). Classification confidence: 0.92 (verified market data). Capital structure on the latest…

Dilution: Medium · Liquidity: Medium
MRKNYSE64

Merck & Co., Inc.

Pharmaceuticals
Price$111.64
Mkt Cap$279.88B
P/E15.3
Revenue$65.01B
Op Income
FCF$12.36B

Merck & Co., Inc. (MRK) is currently classified as Pharmaceuticals within Pharmaceuticals (Healthcare). Classification confidence: 0.92 (verified market data). Capital structure on the latest snaps…

Dilution: Medium · Liquidity: Medium
BSXNYSE64

Boston Scientific Corp

Advanced Medical Equipment & Technology
Price$55.98
Mkt Cap$83.66B
P/E
Revenue$20.07B
Op Income$3.61B
FCF$3.66B

BOSTON SCIENTIFIC CORP (BSX) is currently classified as Advanced Medical Equipment & Technology within Advanced Medical Equipment & Technology (Healthcare). Classification confidence: 0.92 (verifie…

Dilution: Medium · Liquidity: Medium
CRLNYSE64

Charles River Laboratories International, Inc.

Biotechnology & Medical Research
Price$149.93
Mkt Cap
P/E
Revenue$4.02B
Op Income$25.2M
FCF

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) is currently classified as Healthcare Diagnostics within Biotechnology & Medical Research (Healthcare). Classification confidence: 0.92 (verifie…

Dilution: Medium · Liquidity: Medium
MCKNYSE64

Mckesson Corp

Pharmaceuticals
Price$775.97
Mkt Cap
P/E
Revenue$307.13B
Op Income$4.06B
FCF$2.41B

MCKESSON CORP (MCK) is currently classified as Pharmaceuticals & Medical Research within Pharmaceuticals (Healthcare). Classification confidence: 0.92 (verified market data). Capital structure on t…

Dilution: Medium · Liquidity: High
ELVNYSE64

Elevance Health, Inc.

Managed Healthcare
Price$394.07
Mkt Cap
P/E
Revenue$50.18B
Op Income$2.09B
FCF$4.10B

Elevance Health, Inc. (ELV) is currently classified as Healthcare Services & Equipment within Managed Healthcare (Healthcare). Classification confidence: 0.92 (verified market data). Capital struct…

Dilution: Medium · Liquidity: Medium
HLNNYSE64

Haleon plc

Pharmaceuticals
Price$9.25
Mkt Cap
P/E
Revenue
Op Income
FCF

Haleon operates with a capital structure that is not fully quantifiable due to the absence of a financial snapshot, but analyst price targets suggest a wide range of expectations, from 5.39 GBP to…

Dilution: Unknown · Liquidity: Unknown
Latest coverage
No editorial coverage yet for this sector.